Our all-in-one system ExacTrac Dynamic® combines revolutionary new thermal-surface camera technology with real-time X-Ray tracking to support precision patient monitoring during radiotherapy. ExacTrac Dynamic® can be used for a broad range of radiosurgery and radiotherapy treatments.

An article published this year summarizes the 5-year results from a clinical trial that used ExacTrac to administer stereotactic body radiation therapy (SBRT) to patients with localized prostate cancer.

Titled, “Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 Trial”, this trial examined the safety and efficacy of delivering SBRT to patients over two alternative time schedules.

The results of the study, which had been conducted in collaboration with leading international cancer centers, indicate that the treatment works with the expected reduction

in toxicity, regardless of every-other-day vs. once-a-week fractionation.

“Due to its speed, accuracy and reliability, ExacTrac is gaining increased popularity for prostate cancer treatment. The study results are positive, suggesting that SBRT is both an effective and safe treatment technique,” said the study's principal investigator Raymond Miralbell, MD, former Professor at Geneva University Medical School / HUG - Hôpitaux Universitaires de Genève and current Chief Scientific Officer at the Radiation Oncology Department at Centro Médico Teknon - Grupo Quirónsalud in Barcelona and Medical Director of the Quironsalud Protontherapy Center in Madrid.

“The Novalis trial is one of the first prospective studies to test the use of a urethra-sparing SBRT technique. The accurate treatment delivery obtained with a linac-based SBRT technique integrating a 6-degree-of-freedom couch and the ExacTrac system ensured a minimal impact on urinary function and quality of life,” explained one of the

contributing investigators Thomas Zilli, M.D., Professor at USI Università della Svizzera italiana in Lugano, Switzerland and Chairman of the Radiation Oncology Department at Ente Ospedaliero Cantonale (EOC) in Bellinzona, Switzerland.

Interested in learning more? Read through the study summary online: https://pubmed.ncbi.nlm.nih.gov/37001763/

Congratulations to the authors of this article!